Dosis superiores a los 3 gramos diarios, pueden producir diarrea en individuos susceptibles
The latest FDA-approved GLP-1 pill is now on Ro
Additional features include ease of administration, secure packaging, and suitability for broad age groups, further enhancing their desirability among consumers seeking reliable supplementation options
Published Phase 2 effect sizes most prominently the ~24 percent mean body weight reduction at the 12 mg dose tier in the obesity Phase 2 (PMID 37366315) exceed those reported for dual or single agonists at comparable durations, an outcome that researchers attribute to the additional glucagon-arm contribution to body-composition and energy-expenditure pathways
It can also be depleted by chronic stress, alcohol, smoking, digestive issues, cardiovascular disease, illness, and aging because stomach acid production decreases with age, reducing B12 absorption significantly